Attenuation of Monocyte Chemotaxis—A Novel Anti-inflammatory Mechanism of Action for the Cardio-protective Hormone B-Type Natriuretic Peptide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cardiovascular Translational Research

• Publication date

  2013-04-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12265-013-9456-1PMID 23625718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.

  2012cited by this paper
• Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.

  2012cited by this paper
• Heart failure in 2011: Heart failure therapy—technology to the fore

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.

  2012cited by this paper
• Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

  2012cited by this paper
• Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?

  2012cited by this paper
• Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes

  2012cited by this paper
• Metabotropic Regulation of RhoA/Rho-Associated Kinase by L-type Ca2+ Channels: New Mechanism for Depolarization-Evoked Mammalian Arterial Contraction

  2011cited by this paper
• Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

  2011cited by this paper
• Brain natriuretic peptide induces CD8+ T cell death via a caspase 3 associated pathway--implications following heart transplantation.

  2011cited by this paper
• Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

  2011cited by this paper
• Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart

  2010cited by this paper
• The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.

  2010cited by this paper
• Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

  2009cited by this paper
• Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.

  2009cited by this paper
• The immune system and chronic heart failure: is the heart in control?

  2009cited by this paper
• The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury

  2009cited by this paper
• Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload

  2009cited by this paper
• Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation.

  2009cited by this paper
• Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines.

  2008cited by this paper
• State of the art: Using natriuretic peptide levels in clinical practice

  2008cited by this paper
• Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages.

  2008cited by this paper
• Immune-inflammatory activation in heart failure.

  2007cited by this paper
• Critical Role of Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 in the Pathogenesis of Ischemic Cardiomyopathy

  2007cited by this paper
• Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches

  2007cited by this paper
• Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels.

  2007cited by this paper
• TRPC, cGMP-dependent protein kinases and cytosolic Ca2+.

  2007cited by this paper
• Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A.

  2007cited by this paper
• Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages

  2007cited by this paper
• Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment

  2007cited by this paper
• Prognosis in heart failure with a normal ejection fraction.

  2007cited by this paper
• Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.

  2006cited by this paper
• Transient receptor potential channels in essential hypertension

  2006cited by this paper
• BNP‐induced activation of cGMP in human cardiac fibroblasts: Interactions with fibronectin and natriuretic peptide receptors

  2006cited by this paper
• The role of natriuretic peptides in cardioprotection.

  2006cited by this paper
• Systemic inflammation in heart failure – The whys and wherefores

  2006cited by this paper
• Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.

  2005cited by this paper
• Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis

  2005cited by this paper
• Phosphorylation of Serine 188 Protects RhoA from Ubiquitin/Proteasome-Mediated Degradation in Vascular Smooth Muscle Cells

  2005cited by this paper
• Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats.

  2005cited by this paper
• Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.

  2005cited by this paper
• Involvement of the NF-κB/Matrix Metalloproteinase Pathway in Cardiac Fibrosis of Mice Lacking Guanylyl Cyclase/Natriuretic Peptide Receptor A*

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• RhoA activation promotes transendothelial migration of monocytes via ROCK

  2004cited by this paper
• Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?

  2004cited by this paper
• Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell Function

  2004cited by this paper
• Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction

  2004cited by this paper
• Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling

  2004cited by this paper
• Chemokines in the pathogenesis of vascular disease.

  2004cited by this paper
• B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-&bgr; in Primary Human Cardiac Fibroblasts: Fibrosis, Myofibroblast Conversion, Proliferation, and Inflammation

  2004cited by this paper
• Autocrine and paracrine actions of natriuretic peptides in the heart.

  2004cited by this paper
• B-type natriuretic peptide in cardiovascular disease.

  2003cited by this paper
• RhoA and ROCK Promote Migration by Limiting Membrane Protrusions*

  2003cited by this paper
• Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

  2003cited by this paper
• B Type natriuretic peptide: a good omen in myocardial ischaemia?

  2003cited by this paper
• B-Type Natriuretic Peptide: Spectrum of Application. Nesiritide (Recombinant BNP) for Heart Failure

  2003cited by this paper
• Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

  2003cited by this paper
• Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• Fibrosis, Matrix Metalloproteinases, and Inflammation in the Heart of DOCA-Salt Hypertensive Rats: Role of ETA Receptors

  2002cited by this paper
• Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction

  2002cited by this paper
• Idiopathic left ventricular tachycardia localised at the distal end of the posterior fascicle by non-contact activation mapping

  2002cited by this paper
• RhoA is required for monocyte tail retraction during transendothelial migration

  2001cited by this paper
• Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

  2001cited by this paper
• Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo.

  2000cited by this paper
• Cardiac fibrosis in mice lacking brain natriuretic peptide.

  2000cited by this paper
• The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.

  1999cited by this paper
• Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors.

  1999cited by this paper
• Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

  1999cited by this paper
• Expression of extracellular calcium (Ca2+o)-sensing receptor in human peripheral blood monocytes.

  1998cited by this paper
• Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats.

  1997cited by this paper
• Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

  1997cited by this paper
• Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats.

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• Localization of cyclic GMP‐dependent protein kinase in human mononuclear phagocytes

  1995cited by this paper
• Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction.

  1995cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• THE ISOLATION AND SELECTED PROPERTIES OF BLOOD MONOCYTES

  1966cited by this paper

• Cardiac Endocrine Function and Hormonal Interplay in Pediatrics: From Development to Clinical Implications

  2025cites this paper
• Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease

  2025cites this paper
• Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions

  2024cites this paper
• The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease

  2024cites this paper
• A method to measure the receptor-mediated Ca2+ transients in non-adherent THP-1 monocytes using gelatin methacryloyl for immobilization in a bath perfusion system

  2024cites this paper
• Role of Cardiac Natriuretic Peptides in Heart Structure and Function

  2022cites this paper
• Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD

  2021cites this paper
• Monocyte Subsets in Patients with Chronic Heart Failure Treated with Cardiac Resynchronization Therapy

  2021cites this paper
• Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide

  2020cites this paper
• Pathophysiology and molecular signaling in pediatric heart failure and vad theraphy.

  2020cites this paper
• Therapeutic progress and knowledge basis about natriuretic peptide system in heart failure.

  2019cites this paper
• Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity.

  2019cites this paper
• Sp1 mediates phorbol ester (PMA)-induced expression of membrane-bound guanylyl cyclase GC-A in human monocytic THP-1 cells.

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation

  2017cites this paper
• Natriuretic Peptides: The Case of Prostate Cancer

  2017cites this paper
• A Novel Role for Brain Natriuretic Peptide: Inhibition of IL-1β Secretion via Downregulation of NF-kB/Erk 1/2 and NALP3/ASC/Caspase-1 Activation in Human THP-1 Monocyte

  2017cites this paper
• The contributions of dipeptidyl peptidase IV to inflammation in heart failure.

  2016cites this paper
• Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?

  2016cites this paper
• Papel da dipeptidil peptidase IV na fisiopatologia da insuficiência cardíaca

  2015cites this paper
• Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease

  2015cites this paper
• Heart failure in sub‐Saharan Africa: review of the aetiology of heart failure and the role of point‐of‐care biomarker diagnostics

  2015cites this paper
• Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells

  2015influential citation
• Inflammation in Heart Failure with Preserved Ejection Fraction

  2015cites this paper
• Badanie ekspresji wybranych genów odpowiedzialnych za reorganizację cytoszkieletu aktynowego komórek uczestniczących w procesie zapalnym u chorych na reumatoidalne zapalenie stawów

  2014cites this paper
• Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection

  2014cites this paper
• Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice.

  2014cites this paper
• Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target

  2014cites this paper
• Biomarkers and Heart Disease: What is Translational Success?

  2013cites this paper